1. Home
  2. INTT vs ORGO Comparison

INTT vs ORGO Comparison

Compare INTT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

N/A

Current Price

$14.16

Market Cap

148.4M

Sector

Technology

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$0.77

Market Cap

127.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTT
ORGO
Founded
1981
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.4M
127.6M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
INTT
ORGO
Price
$14.16
$0.77
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
★ $20.00
$2.00
AVG Volume (30 Days)
122.2K
★ 929.1K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1600.00
EPS
★ 0.06
N/A
Revenue
$66,801,000.00
★ $564,169,000.00
Revenue This Year
$22.35
N/A
Revenue Next Year
$7.07
$37.55
P/E Ratio
$263.00
★ N/A
Revenue Growth
★ 66.06
17.04
52 Week Low
$7.07
$0.81
52 Week High
$20.00
$7.08

Technical Indicators

Market Signals
Indicator
INTT
ORGO
Relative Strength Index (RSI) 52.80 16.25
Support Level $12.54 N/A
Resistance Level $15.25 $2.57
Average True Range (ATR) 0.95 0.08
MACD 0.09 -0.02
Stochastic Oscillator 49.87 1.64

Price Performance

Historical Comparison
INTT
ORGO

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: